Menu
Logo

Disease areas

Multiple Myeloma

Multiple Myeloma

Lymphoma

Chronic Lymphocytic Leukemia
Waldenström macroglobulinemia
Mantelcellymfoom

Myeloid Leukemia

Myeloid Leukemia

Product portfolio in hematology

Imbruvica®

Imbruvica (ibrutinib) is a Bruton tyrosine kinase (BTK) inhibitor for the treatment of chronic lymphocytic leukaemia (CLL), mantle cell lymphoma (MCL) and Waldenström macroglobulinemia (WM). Discover scientific information, materials for you and your patients, therapy management and much more.

Darzalex®

Darzalex (daratumumab) is a targeted monoclonal antibody for the treatment of multiple myeloma (MM). Discover scientific information, materials for you and your patients, guidelines and much more.

CP-217996 - March 2021